Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
Saved in:
| Title: | Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer. |
|---|---|
| Authors: | Domingos-Pereira, Sonia1, Cesson, Valérie1, Chevalier, Mathieu F.1, Derré, Laurent1, Jichlinski, Patrice1, Nardelli-Haefliger, Denise1 |
| Source: | OncoImmunology. 2017, Vol. 6 Issue 1, p1-1. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!